×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
Investor Meeting on Q3 FY2016 Results · Q3 FY16 Actual Q3 FY2016 Revenue Change 7 Japan prescription pharmaceuticals Japan OTC Japan medical devices Asia EMEA US* Q3 FY15 94.3 8.1
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form